169 related articles for article (PubMed ID: 6650002)
1. [Treatment of congenital toxoplasmosis].
Couvreur J; Desmonts C
Zentralbl Gynakol; 1983; 105(17):1108-12. PubMed ID: 6650002
[No Abstract] [Full Text] [Related]
2. [New viewpoints on the treatment of toxoplasmosis].
Kocher R; Haensch G
Dtsch Med Wochenschr; 1973 Oct; 98(41):1920-3. PubMed ID: 4206221
[No Abstract] [Full Text] [Related]
3. [Treatment of congenital toxoplasmosis. Clinical and biological results (author's transl)].
Couvreur J; Nottin N; Desmonts G
Ann Pediatr (Paris); 1980 Dec; 27(10):647-52. PubMed ID: 7212550
[No Abstract] [Full Text] [Related]
4. [Letter: Significance of Toxoplasma infections for public health].
Koppe JG
Ned Tijdschr Geneeskd; 1975 Sep; 119(38):1477. PubMed ID: 1165816
[No Abstract] [Full Text] [Related]
5. Treatment of congenital toxoplasmosis.
Wilson CB
Pediatr Infect Dis J; 1990 Sep; 9(9):682-3. PubMed ID: 2235199
[No Abstract] [Full Text] [Related]
6. [Sulfadiazine, pyrimethamine, spiramycin and folic acid in congenital toxoplasmosis].
Sedan J
Mars Med; 1967; 104(4):343-5. PubMed ID: 5621539
[No Abstract] [Full Text] [Related]
7. [Apropos of a case of congenital toxoplasmosis].
Lacomme M; Lewin D; Amiel-Tison C; Cheynier JM
Bull Fed Soc Gynecol Obstet Lang Fr; 1967; 19(3):208-13. PubMed ID: 5584037
[No Abstract] [Full Text] [Related]
8. Considerations on some cases of repeated abortions probabily due to Toxoplasma gondii (author's transl).
Carollo F; Spanó C; Dardanoni L
Acta Eur Fertil; 1972 Mar; 3(1):5-18. PubMed ID: 4679561
[No Abstract] [Full Text] [Related]
9. Congenital toxoplasmosis. A prospective study of 378 pregnancies.
Desmonts G; Couvreur J
N Engl J Med; 1974 May; 290(20):1110-6. PubMed ID: 4821174
[No Abstract] [Full Text] [Related]
10. Toxoplasmosis in pregnancy and its transmission to the fetus.
Desmonts G; Couvreur J
Bull N Y Acad Med; 1974 Feb; 50(2):146-59. PubMed ID: 4521728
[No Abstract] [Full Text] [Related]
11. [In utero treatment of congenital toxoplasmosis with a pyrimethamine-sulfadiazine combination].
Couvreur J
Presse Med; 1991 Jun; 20(24):1136. PubMed ID: 1830148
[No Abstract] [Full Text] [Related]
12. [Postnatal ocular toxoplasmosis in a grown woman].
Bowles EC; Hillenius JM; Biesma DH; Kortbeek LM; de Jongh BM
Ned Tijdschr Geneeskd; 2009 Feb; 153(7):292-6. PubMed ID: 19291946
[No Abstract] [Full Text] [Related]
13. [Difficulties in the diagnosis and treatment of toxoplasmosis].
Morales Castillo ME; Cedillo Rivera R
Bol Med Hosp Infant Mex; 1982 May; 39(5):361-6. PubMed ID: 7104080
[No Abstract] [Full Text] [Related]
14. Phenotypes and functions of lymphocytes in congenital toxoplasmosis.
McLeod R; Mack DG; Boyer K; Mets M; Roizen N; Swisher C; Patel D; Beckmann E; Vitullo D; Johnson D
J Lab Clin Med; 1990 Nov; 116(5):623-35. PubMed ID: 2146348
[TBL] [Abstract][Full Text] [Related]
15. [Congenital toxoplasmosis; observations on the recommendation of the Public Health Council].
van der Veen J
Ned Tijdschr Geneeskd; 1984 Jan; 128(3):131-3. PubMed ID: 6700748
[No Abstract] [Full Text] [Related]
16. [Fetal toxoplasmosis. In utero treatment with pyrimethamine sulfamides].
Couvreur J; Thulliez P; Daffos F; Aufrant C; Bompard Y; Gesquière A; Desmonts G
Arch Fr Pediatr; 1991; 48(6):397-403. PubMed ID: 1929726
[TBL] [Abstract][Full Text] [Related]
17. Treatment of infants with congenital toxoplasmosis: tolerability and plasma concentrations of sulfadiazine and pyrimethamine.
Schmidt DR; Hogh B; Andersen O; Hansen SH; Dalhoff K; Petersen E
Eur J Pediatr; 2006 Jan; 165(1):19-25. PubMed ID: 16133245
[TBL] [Abstract][Full Text] [Related]
18. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous determination of pyrimethamine, sulfadiazine and N-acetyl-sulfadiazine in plasma for monitoring infants in treatment of congenital toxoplasmosis.
Johannessen JK; Christiansen I; Schmidt DR; Petersen E; Hansen SH
J Pharm Biomed Anal; 2005 Jan; 36(5):1093-8. PubMed ID: 15620537
[TBL] [Abstract][Full Text] [Related]
20. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.
McLeod R; Boyer K; Karrison T; Kasza K; Swisher C; Roizen N; Jalbrzikowski J; Remington J; Heydemann P; Noble AG; Mets M; Holfels E; Withers S; Latkany P; Meier P;
Clin Infect Dis; 2006 May; 42(10):1383-94. PubMed ID: 16619149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
